Company Financials
BELLUS Health Inc. Financials
Canadian dollar
business
BELLUS Health Inc. Company Profile
Main Stock Listing
TSX: BLU
Market Capitalization C$2.47 Billion as of June 1, 2023
Market Cap History
Valuations Metrics as of Jan. 25, 2025
| Trailing PE | -29.56 |
| Forward PE | -15.58 |
| Price to Sales TTM | C$154631.38 |
| Price to Book MRQ | C$6.69 |
| Enterprise to Revenue | 149258.45 |
| Enterprise to EBITDA | -32.82 |
Financial Reports as of Mar. 31, 2023
Financials
| Fiscal Year Ends | 2022-12-31 |
| Most Recent Quarter | 2023-03-31 |
| Profit Margin | % |
| Operating Margin | -474637.50% |
| Return on Assets TTM | -18.66% |
| Return on Equity TTM | -19.46% |
Income Statement
| Revenue TTM | C$16,000 |
| Revenue per Share TTM | C$0.00 |
| Quarterly Revenue Growth | -25.00% |
| Gross Profit TTM | C$0 |
| EBITDA | C$0 |
| Net Income to Common TTM | C$-76,080,000 |
| Diluted EPS TTM | C$-0.66 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | C$8,581,000 |
| Total Cash per Share MRQ | C$0.07 |
| Total Debt MRQ | C$ |
| Total Debt to Equity MRQ | 0.00 |
| Current Ratio MRQ | 33.42 |
| Book Value per Share MRQ | C$2.91 |
Cash Flow
| Operating Cash Flow TTM | C$-67,927,000 |
| Levered Free Cash Flow TTM | C$-76,080,000 |
BLU Stock Info as of Jan. 25, 2025
Stock Statistics
| Shares Outstanding | 126,812,000 |
| Float Shares | None |
| Avg 10 Volume | 113,584 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | % |
| % Held by Institutions | % |
Stock Price Summary
| Beta | |
| Fifty Two Week Low | C$0.00 |
| Fifty Two Week High | C$0.00 |
| Fifty Two Week Change | % |
| Day 50 MA | C$0.00 |
| Day 200 MA | C$0.00 |
Dividends and Splits
| Forward Annual Dividend Rate | C$ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | C$ |
| Trailing Annual Dividend Yield | % |
| Payout Ratio | % |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date | 2019-08-19 |